Idexx Laboratories [IDXX] vs Agilent Technologies [A] Detailed Stock Comparison

Idexx Laboratories, Inc.

NASDAQ
Loading...

Agilent Technologies Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Idexx Laboratories, Inc. wins in 10 metrics, Agilent Technologies Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Idexx Laboratories, Inc. Agilent Technologies Inc. Better
P/E Ratio (TTM) 42.92 25.67 Agilent Technologies Inc.
Price-to-Book Ratio 27.85 4.76 Agilent Technologies Inc.
Debt-to-Equity Ratio 60.83 51.39 Agilent Technologies Inc.
PEG Ratio 2.41 -7.19 Idexx Laboratories, Inc.
EV/EBITDA 31.12 17.32 Agilent Technologies Inc.
Profit Margin (TTM) 24.62% 18.26% Idexx Laboratories, Inc.
Operating Margin (TTM) 29.76% 22.86% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 29.76% 22.86% Idexx Laboratories, Inc.
Return on Equity 66.20% 19.95% Idexx Laboratories, Inc.
Return on Assets (TTM) 25.59% 8.53% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $1.04B $1.15B Agilent Technologies Inc.
Dividend Yield N/A 0.68% N/A
1-Year Return 7.30% 10.90% Agilent Technologies Inc.
Price-to-Sales Ratio (TTM) 10.38 4.65 Agilent Technologies Inc.
Enterprise Value $46.85B $34.13B Idexx Laboratories, Inc.
EV/Revenue Ratio 10.89 4.83 Agilent Technologies Inc.
Gross Profit Margin (TTM) 60.35% 52.61% Idexx Laboratories, Inc.
Revenue per Share (TTM) $54 $25 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $13.07 $4.53 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.72 1.30 Agilent Technologies Inc.
Short % of Float 2.74% 1.83% Agilent Technologies Inc.

Idexx Laboratories, Inc. vs Agilent Technologies Inc. Stock Performance Analysis

Loading Price Chart...

IDXX
A

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%
Agilent Technologies Inc.-3.41%-2.11%3.78%7.87%-3.22%-4.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%
Agilent Technologies Inc.10.90%7.19%-10.46%186.24%282.67%444.17%

Performance & Financial Health Analysis: Idexx Laboratories, Inc. vs Agilent Technologies Inc.

MetricIDXXA
Market Information
Market Cap i$44.66B$32.65B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i480,5021,922,585
90 Day Avg. Volume i516,1141,892,452
Last Close$570.00$131.46
52 Week Range$506.91 - $769.98$108.35 - $160.27
% from 52W High-25.97%-17.98%
All-Time High$769.98 (Nov 26, 2025)$179.57 (Aug 30, 2021)
% from All-Time High-25.97%-26.79%
Growth Metrics
Quarterly Revenue Growth0.14%0.07%
Quarterly Earnings Growth0.15%-0.04%
Financial Health
Profit Margin (TTM) i0.25%0.18%
Operating Margin (TTM) i0.30%0.23%
Return on Equity (TTM) i0.66%0.20%
Debt to Equity (MRQ) i60.8351.39
Cash & Liquidity
Book Value per Share (MRQ)$20.14$24.44
Cash per Share (MRQ)$2.26$6.22
Operating Cash Flow (TTM) i$1.18B$1.40B
Levered Free Cash Flow (TTM) i$790.74M$855.88M
Dividends
Last 12-Month Dividend Yield iN/A0.68%
Last 12-Month Dividend iN/A$1.01

Valuation & Enterprise Metrics Analysis: Idexx Laboratories, Inc. vs Agilent Technologies Inc.

MetricIDXX (Apr 24, 2026)A (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i42.9225.67
Forward P/E i34.1917.67
PEG Ratio i2.41-7.19
Price to Sales (TTM) i10.384.65
Price to Book (MRQ) i27.854.76
Market Capitalization
Market Capitalization i$44.66B$32.65B
Enterprise Value i$46.85B$34.13B
Enterprise Value Metrics
Enterprise to Revenue i10.894.83
Enterprise to EBITDA i31.1217.32
Risk & Other Metrics
Beta i1.721.30
Book Value per Share (MRQ) i$20.14$24.44

Financial Statements Comparison: Idexx Laboratories, Inc. vs Agilent Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIDXX (2025)A (2025)
Revenue/Sales i4.30B6.95B
Cost of Goods Sold i1.64B3.31B
COGS % of Revenue i38.2%47.6%
Gross Profit i2.66B3.64B
Gross Margin i61.8%52.4%
Research & Development i251.21M455.00M
Operating Income (EBIT) i1.36B1.48B
Operating Margin i31.6%21.3%
EBITDA i1.51B1.84B
EBITDA Margin i35.0%26.4%
Pre-Tax Income i1.32B1.44B
Pre-Tax Income % of Revenue i30.8%20.7%
Income Tax i264.73M132.00M
Income Tax % of Revenue i6.2%1.9%
Net Income (Profit) i1.06B1.30B
Profit Margin i24.6%18.8%

Balance Sheet & Liquidity Metrics

MetricIDXX (2025)A (2025)
Cash & Equivalents i180.07M1.79B
Total Current Assets i1.41B4.59B
Total Current Assets % of Revenue i32.9%66.1%
Total Current Liabilities i1.15B2.35B
Total Current Liabilities % of Revenue i26.7%33.8%
Long-Term Debt i475.99M3.05B
Long-Term Debt % of Revenue i11.1%43.9%
Total Shareholders Equity i1.61B6.74B
Retained Earnings i6.39B1.39B
Retained Earnings % of Revenue i148.5%20.0%
Property, Plant & Equipment i123.23M0

Cash Flow Statement Comparison

MetricIDXX (2025)A (2025)
Operating Cash Flow i1.17B1.51B
Operating Cash Flow % of Revenue i27.3%21.7%
Capital Expenditures i-124.68M-407.00M
Free Cash Flow i1.04B1.15B
FCF Margin i24.2%16.6%
Debt Repayment i-428.39M-3.00M
Common Stock Repurchase i-1.22B-425.00M

Short Interest & Institutional Ownership Analysis

MetricIDXXA
Shares Short i1.91M4.55M
Short Ratio i3.851.93
Short % of Float i2.74%1.83%
Shares Outstanding i79.71M282.70M
Float Shares i78.75M281.64M
% Held by Insiders i0.71%0.19%
% Held by Institutions i96.04%93.87%
% Held by Public i3.25%5.94%

Dividend Analysis & Yield Comparison: Idexx Laboratories, Inc. vs Agilent Technologies Inc.

MetricIDXXA
Last 12-Month Dividend iN/A$1.01
Last 12-Month Dividend Yield iN/A0.68%
3-Year Avg Annual Dividend iN/A$0.97
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.91
Ex-Dividend DateN/AJan 06, 2026